National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

Found 253 cases where Age is under-19 and Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Patient Did Not Die and Hospitalized and Vaccination Date from '2021-07-01' to '2021-07-31'

Government Disclaimer on use of this data



Case Details

This is page 11 out of 26

Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next


VAERS ID: 1633163 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Arizona  
Vaccinated:2021-07-30
Onset:2021-08-23
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-08-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA7484 / 1 - / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Chest pain, Human rhinovirus test positive, Hypoxia, Lung infiltration, Pneumonia, Pulmonary embolism, Rhinovirus infection, SARS-CoV-2 test negative
SMQs:, Asthma/bronchospasm (broad), Interstitial lung disease (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: asthma, obesity
Allergies: none
Diagnostic Lab Data: 8/24/2021: CT angiogram chest: +bilateral segmental pulmonary emboli COVID19 negative x 3 tests (PCR) +rhinovirus PCR - NP swab
CDC Split Type:

Write-up: Patient was hospitalized with hypoxia, chest pain 3 weeks after 1st shot of COVID19 Pfizer. Found with bilateral segmental pulmonary emboli and small infiltrates bilateral, also had +PCR for rhinovirus. Being treated for pulmonary emboli and pneumonia with anticoagulation and antibiotics Improved since anticoagulation started, unclear if this is a side effect from COVID19 vaccine, patient will be getting 2nd shot while on anticoagulation.


VAERS ID: 1636620 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-07-26
Onset:2021-08-14
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-08-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0191 / 1 - / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Chest pain, Computerised tomogram abdomen abnormal, Pulmonary embolism, Pulmonary infarction, Pulmonary necrosis, Urinary tract infection
SMQs:, Interstitial lung disease (narrow), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, venous (narrow), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Lo LoEstrin
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Abdominal CT and CT angiogram
CDC Split Type:

Write-up: 8/12/2021 left sided chest pain 8/14/2021 UTI with continued left chest pain 8/14/2021 abdominal CT showed left lower lobe necrosis and admitted. 8/15/2021 CT angiogram of chest showed left lower lobe pulmonary emboli with left lower lobe pulmonary infarct. Pt anticoagulated. 8/18/2021 Discharged on Eliquis.


VAERS ID: 1636772 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-07-26
Onset:2021-08-13
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-08-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / IM

Administered by: Private       Purchased by: ?
Symptoms: Alanine aminotransferase normal, Amphetamines negative, Anion gap, Aspartate aminotransferase normal, Ataxia, Barbiturates negative, Basophil count decreased, Basophil percentage, Benzodiazepine drug level, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood calcium normal, Blood cannabinoids, Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood magnesium normal, Blood potassium normal, Blood sodium normal, Blood thyroid stimulating hormone decreased, Blood urea normal, Blood urine absent, C-reactive protein normal, Carbon dioxide normal, Computerised tomogram head normal, Cytomegalovirus test negative, Dizziness, Drug screen negative, Dysmetria, Enterovirus test negative, Eosinophil count decreased, Eosinophil percentage, Epstein-Barr virus test, Full blood count normal, Gait disturbance, Glomerular filtration rate, Glucose urine absent, Haematocrit normal, Haemoglobin normal, Head discomfort, Herpes simplex test negative, Human herpes virus 6 serology negative, Immunoglobulin therapy, Influenza virus test negative, Lumbar puncture, Lymphocyte count, Lymphocyte percentage, Magnetic resonance imaging head normal, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume normal, Metabolic function test, Metabolic function test normal, Methaemoglobin urine absent, Monocyte count decreased, Monocyte percentage, Neisseria test, Neurological examination normal, Neutrophil count, Neutrophil percentage, Nitrite urine absent, Platelet count normal, Protein total normal, Protein urine absent, Red blood cell count increased, Red blood cell sedimentation rate normal, Red cell distribution width, SARS-CoV-2 test negative, Specific gravity urine normal, Speech disorder, Streptococcus test negative, Urine analysis normal, Urine ketone body absent, Urine leukocyte esterase, Varicella zoster virus infection, Viral infection, Vitamin B12 increased, Vitamin D decreased, Weight decreased, White blood cell count decreased, pH urine
SMQs:, Haematopoietic leukopenia (narrow), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Hypothyroidism (broad), Hyperthyroidism (broad), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Opportunistic infections (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: He had an acute diarrheal illness from 8/11-8/13 with no associated fever, vomiting, or nausea.
Preexisting Conditions:
Allergies: None
Diagnostic Lab Data: CT head (8/18/2021) - negative for intracranial pathology 8/18/2021 5:57 PM - CBC Component Value Flag Ref Range Units Status Lab Hemoglobin 15.1 13.3 - 16.9 g/dL Final HNL1 Hematocrit 43.1 38.0 - 47.0 % Final HNL1 WBC 4.7 3.8 - 10.4 thou/cmm Final HNL1 RBC 5.21 4.30 - 5.70 mill/cmm Final HNL1 Platelet Count 164 139 - 320 thou/cmm Final HNL1 MPV 9.0 7.5 - 11.3 fL Final HNL1 MCV 83 83 - 98 fL Final HNL1 MCH 29.0 26.3 - 31.7 pg Final HNL1 MCHC 35.1 32.5 - 35.2 g/dL Final HNL1 RDW 13.0 11.4 - 13.5 % Final HNL1 Differential Type AUTO Final HNL1 Absolute Neutrophils 3.0 1.4 - 6.1 thou/cmm Final HNL1 Absolute Lymphocytes 1.1 1.0 - 3.2 thou/cmm Final HNL1 Absolute Monocytes 0.4 0.2 - 0.8 thou/cmm Final HNL1 Absolute Eosinophils 0.2 0.1 - 0.2 thou/cmm Final HNL1 Absolute Basophils 0.0 0.0 - 0.1 thou/cmm Final HNL1 Neutrophils 63 % Final HNL1 Lymphocytes 24 % Final HNL1 Monocytes 8 % Final HNL1 Eosinophils 4 % Final HNL1 Basophils 1 % Final HNL1 8/18/2021 6:12 PM - CMP Component Value Flag Ref Range Units Status Lab Glucose 121 High 70 - 100 mg/dL Final HNL10 BUN 12 7 - 25 mg/dL Final HNL10 Creatinine 0.95 0.70 - 1.30 mg/dL Final HNL10 Sodium 138 136 - 145 mmol/L Final HNL10 Potassium 4.5 3.5 - 5.1 mmol/L Final HNL10 Chloride 102 100 - 108 mmol/L Final HNL10 Carbon Dioxide 29 21 - 31 mmol/L Final HNL10 Calcium 9.9 8.6 - 10.2 mg/dL Final HNL10 Alkaline Phosphatase 137 High 34 - 104 U/L Final HNL10 Albumin 4.8 3.5 - 5.7 g/dL Final HNL10 Bilirubin, Total 0.7 0.2 - 1.1 mg/dL Final HNL10 Protein, Total 7.7 6.4 - 8.9 g/dL Final HNL10 AST 12 Low 13 - 39 U/L Final HNL10 ALT 7 7 - 52 U/L Final HNL10 Anion Gap 7 4 - 18 Final HNL10 eGFR, Final HNL10 Not performed on patients less than 18 years of age or greater than 97 years of age eGFR, Final HNL10 Not performed on patients less than 18 years of age or greater than 97 years of age eGFR Comment Not applicable Final HNL10 8/18/2021 6:12 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Magnesium 2.1 1.6 - 2.3 mg/dL Final HNL10 8/19/2021 5:09 AM - Interface, Lab Medicine Results In Specimen Information: Nasopharynx (LAB); Separate Accession Component Value Flag Ref Range Units Status Lab SARS Coronavirus 2 PCR Not Detected Not Detected Final HNL1 8/18/2021 6:38 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Specific Gravity, Urine 1.020 1.003 - 1.030 Final HNL10 pH, Urine 6 4.5 - 8.0 Final HNL10 Protein, Urine Negative Negative mg/dL Final HNL10 Glucose, Urine Negative Negative mg/dL Final HNL10 Ketone, Urine Negative Negative mg/dL Final HNL10 Blood, Urine Negative Negative mg/dL Final HNL10 Leukocytes Esterase Negative Negative /uL Final HNL10 Nitrite, Urine Negative Negative Final HNL10 Comment SEE NOTES Final HNL10 Comment: Microscopic analysis not performed on urine with negative contributing biochemical results for Protein, Blood, Leukocyte Esterase, or Nitrates. 8/18/2021 6:50 PM - Interface, Lab Medicine Results In Component Lab Amphetamines, Urine HNL10 Negative Comment: Detection limit: 500 ng/mL Cannabinoids, Urine HNL10 Negative Comment: Detection limit: 50 ng/mL Cocaine, Urine HNL10 Negative Comment: Detection limit: 150 ng/mL Opiates, Urine HNL10 Negative Comment: Detection limit: 300 ng/mL Phencyclidine, Urine HNL10 Negative Comment: Detection limit: 25 ng/mL Barbiturates, Urine HNL10 Negative Comment: Detection limit: 200 ng/mL Benzodiazepine, Urine HNL10 Negative Comment: Detection limit: 200 ng/mL Methadone, Urine HNL10 Negative Comment: Detection limit: 300 ng/mL Oxycodone, Urine HNL10 Negative Comment: Detection limit: 100 ng/mL 8/23/2021 1:36 AM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Hemoglobin 14.6 13.3 - 16.9 g/dL Final HNL10 Hematocrit 42.7 38.0 - 47.0 % Final HNL10 WBC 6.3 3.8 - 10.4 thou/cmm Final HNL10 RBC 5.11 4.30 - 5.70 mill/cmm Final HNL10 Platelet Count 193 139 - 320 thou/cmm Final HNL10 MPV 9.4 7.5 - 11.3 fL Final HNL10 MCV 84 83 - 98 fL Final HNL10 MCH 28.5 26.3 - 31.7 pg Final HNL10 MCHC 34.2 32.5 - 35.2 g/dL Final HNL10 RDW 13.1 11.4 - 13.5 % Final HNL10 Differential Type AUTO Final HNL10 Absolute Neutrophils 3.2 1.4 - 6.1 thou/cmm Final HNL10 Absolute Lymphocytes 2.3 1.0 - 3.2 thou/cmm Final HNL10 Absolute Monocytes 0.3 0.2 - 0.8 thou/cmm Final HNL10 Absolute Eosinophils 0.4 High 0.1 - 0.2 thou/cmm Final HNL10 Absolute Basophils 0.0 0.0 - 0.1 thou/cmm Final HNL10 Neutrophils 51 % Final HNL10 Lymphocytes 37 % Final HNL10 Monocytes 5 % Final HNL10 Eosinophils 6 % Final HNL10 Basophils 1 % Final HNL10 8/23/2021 1:55 AM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Glucose 98 70 - 100 mg/dL Final HNL10 BUN 15 7 - 25 mg/dL Final HNL10 Creatinine 0.96 0.70 - 1.30 mg/dL Final HNL10 Sodium 138 136 - 145 mmol/L Final HNL10 Potassium 4.0 3.5 - 5.1 mmol/L Final HNL10 Chloride 102 100 - 108 mmol/L Final HNL10 Carbon Dioxide 29 21 - 31 mmol/L Final HNL10 Calcium 9.6 8.6 - 10.2 mg/dL Final HNL10 Alkaline Phosphatase 137 High 34 - 104 U/L Final HNL10 Albumin 4.6 3.5 - 5.7 g/dL Final HNL10 Bilirubin, Total 0.5 0.2 - 1.1 mg/dL Final HNL10 Protein, Total 7.5 6.4 - 8.9 g/dL Final HNL10 AST 10 Low 13 - 39 U/L Final HNL10 ALT 7 7 - 52 U/L Final HNL10 Anion Gap 7 4 - 18 Final HNL10 eGFR, Final HNL10 Not performed on patients less than 18 years of age or greater than 97 years of age eGFR, Final HNL10 Not performed on patients less than 18 years of age or greater than 97 years of age eGFR Comment Not applicable Final HNL10 8/23/2021 1:44 AM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Sed Rate 2 0 - 15 mm/hr Final HNL10 8/23/2021 9:40 AM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab C-Reactive Protein <3.0 <7.0 mg/L Final HNL1 8/24/2021 11:09 AM - Interface, Lab Medicine Results In Specimen Information: Serum (LAB); Blood Component Value Flag Ref Range Units Status Lab Lyme Ab (IgG + IgM) 0.67 <0.91 Index Final HNL1 Comment: ELISA screen negative for total (IgG+IgM) antibodies to Borrelia burgdorferi, the causative agent of Lyme disease. Lyme IgM Ab 0.44 <0.91 Index Final HNL1 Comment: ELISA screen negative for IgM antibodies to Borrelia burgdorferi, the causative agent of Lyme disease. No evidence of acute Lyme disease at this time. Comment SEE NOTES Final HNL1 Comment: Reference Range Negative <0.91 Indeterminate/Equivocal 0.91-1.09 Positive $g1.10 MRI /MRA/MRV brain (8/23/2021) - non-diagnostic due to artifact from patient''s braces Dental consult (8/24/2021) - inpatient brace removal MRI brain/C-spine/T-spine/L-spine (8/24/2021) - negative for pathology Lumbar puncture of spine (8/25/2021) 8/25/2021 3:24 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Glucose, CSF 59 40 - 70 mg/dL Final HNL2 Testing Performed By Lab - Abbreviation Name Director Address Valid Date Range 210036619-HNL2 (HNL2) MD 08/19/19 1828-Present 8/25/2021 3:24 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Protein, Total, CSF 42 15 - 45 mg/dL Final HNL2 8/26/2021 11:44 AM - Interface, Lab Medicine Results In Specimen Information: CSF, cerebrospinal fluid (LAB, NGYN) Component Lab Special Requests HNL1 NONE Direct Exam HNL1 No Neutrophils noted Direct Exam HNL1 No organisms observed Culture Results HNL1 NO GROWTH <24 HOURS 8/25/2021 3:21 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Tube Counted 3 Final HNL2 Volume, Tube Counted 2.0 mL Final HNL2 Appear Pre-Centrifugation Clear Final HNL2 Color Pre-Centrifugation Colorless Final HNL2 Color Post-Centrifugation Final HNL2 Supernatent is colorless RBC 41 High 0 - 5 /cmm Final HNL2 WBC 0 0 - 7 /cmm Final HNL2 Neutrophils 0 - 2 % Final HNL2 Test cancelled: test not warranted. Lymphocytes 63 - 99 % Final HNL2 Test cancelled: test not warranted. Monocytes 3 - 37 % Final HNL2 Test cancelled: test not warranted. Other Cells % Final HNL2 Test cancelled: test not warranted. Reactive Lymphocytes % Final HNL2 Test cancelled: test not warranted. Histiocytes % Final HNL2 Test cancelled: test not warranted. 8/25/2021 6:24 PM - Interface, Lab Medicine Results In Specimen Information: CSF, cerebrospinal fluid (LAB, NGYN) Component Value Flag Ref Range Units Status Lab E. coli K1 Not Detected Not Detected Final HNL1 H. influenzae Not Detected Not Detected Final HNL1 L. monocytogenes Not Detected Not Detected Final HNL1 N. meningitidis Not Detected Not Detected Final HNL1 S. agalactiae Not Detected Not Detected Final HNL1 S. pneumoniae Not Detected Not Detected Final HNL1 Cytomegalovirus Not Detected Not Detected Final HNL1 Enterovirus Not Detected Not Detected Final HNL1 H. simplex 1 Not Detected Not Detected Final HNL1 H. simplex 2 Not Detected Not Detected Final HNL1 Herpes virus 6 Not Detected Not Detected Final HNL1 Parechovirus Not Detected Not Detected Final HNL1 V. zoster Not Detected Not Detected Final HNL1 C. neoformans/gattii Not Detected Not Detected Final HNL1 8/26/2021 1:04 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Antinuclear Abs Absent Absent Final HNL1 Comment: 8/25/2021 8:25 PM - Interface, Lab Medicine Results In Specimen Information: Serum (LAB); Blood Component Value Flag Ref Range Units Status Lab EBV VCA IgM Ab <10.0 <36.0 U/mL Final HNL1 Comment: Interpretation Negative <36.0 Equivocal 36.0-43.9 Positive $g43.9 EBV VCA IgG Ab 42.8 High <18.0 U/mL Final HNL1 Comment: Interpretation Negative <18.0 Equivocal 18.0-21.9 Positive $g21.9 EBV EA Ab <5.0 <9.0 U/mL Final HNL1 Comment: Interpretation Negative <9.0 Equivocal 9.0-10.9 Positive $g10.9 EBV EBNA Ab 7.8 <18.0 U/mL Final HNL1 Comment: Interpretation Negative <18.0 Equivocal 18.0-21.9 Positive $g21.9 Interpretation SEE NOTES Final HNL1 Comment: Serological results compatible with recent EBV infection. 8/25/2021 6:03 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Vitamin B12 1,044 $g211 pg/mL Final HNL1 8/25/2021 5:06 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Thyroid Stimulating Hormone 1.17 0.46 - 3.98 uIU/mL Final HNL1 8/26/2021 12:39 PM - Interface, Lab Medicine Results In Component Value Flag Ref Range Units Status Lab Vitamin D, 25-OH 24 Low 30 - 100 ng/mL Final HNL1 Comment: Interpretive information: Total Vitamin D, 25-Hydroxy This assay quantifies the sum of vitamin D3, 25-hydroxy and vitamin D2, 25-hydroxy. <10 ng/mL Deficiency 10-30 ng/mL Insufficiency 30-100 ng/mL Sufficiency $g100 ng/mL Toxicity Added on CSF EBV PCR
CDC Split Type:

Write-up: Patient is a 15 yo M with no significant past medical history who presented with a two week history of worsening ataxia associated with "heaviness" of the head and 15 lb weight loss. Symptoms started on 8/13. Patient received pfizer COVID19 vaccine on 7/26/2021 and 8/16/2021. Initially presented to OSH ED on 8/18 for symptoms where a workup was negative including CBC, CMP, Magnesium, UA, COVID, UDS. CT Head showed no mass effect, hemorrhage or infarction. Was diagnosed with Viral Syndrome and discharged. Two days later (8/20/2021) instability while walking continued as patient could hardly walk. Yesterday evening continued ataxic gait with lightheadedness only on ambulation. No fevers, chills, chest pain, shortness of breath, abdominal pain, nausea, vomiting, vertigo. Of note father states that speech has changed in terms of fluency. Went back to ER on 8/23/2021 where CBC, CMP, ESR, CRP were all negative. Transferred to hospital for further evaluation and workup. In the hospital he has had unchanged ataxia, workup has been negative thus far. Has normal neurologic exam other than dysmetria on finger-to-nose testing, heel-to shin. Has ataxia falling to left side. Still hospitalized but starting on IVIG empirically.


VAERS ID: 1646129 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-07-29
Onset:2021-07-30
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-08-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: COVID-19, Dyspnoea, Oxygen saturation, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Asthmatic (she had first asthma attack and end up in hospital at age 4)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210730; Test Name: pulse oximeter; Result Unstructured Data: Test Result:84 to 86 %; Comments: oxygen levels; Test Date: 20210801; Test Name: PCR COVID test; Test Result: Positive ; Test Date: 20210730; Test Name: Rapid COVID test; Test Result: Positive
CDC Split Type: USPFIZER INC202100985602

Write-up: diagnosed with COVID-19; shortness of breath; This is a spontaneous report from a Pfizer sponsored program. A contactable Nurse reported for Patient (Reporter''s daughter). A 16-year-old female received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Deltoid Left, on 29Jul2021 at 11:00 (age at vaccination: 16 years), as a single dose for COVID-19 immunization. The patient''s medical history included ongoing asthmatic (she had first asthma attack and end up in hospital at age 4). Concomitant medications were not reported. The reporter called on behalf of her daughter (patient) who received the COVID-19 Vaccine Thursday 29Jul2021. The next day, on 30Jul2021, after patient received the vaccine, the patient started having shortness of breath and her mother, ICU nurse, took her to the ER where she was diagnosed with COVID-19. The patient was hospitalized on an unspecified date. She had put the pulse oximeter on and oxygen level was 84 to 86%. The patient''s lungs and there were no crackles. The patient was taking shallow breaths. In the ER they gave her a breathing treatment and ordered a spacer for her inhaler. She has been ok since. The reporter had questions regarding her 2nd dose of the vaccination and if the series will have to be restarted. Caller stated that when she was caring for patients in the ICU they were advising them at discharge to wait 6-8 weeks to get the vaccine after having COVID related illness/hospitalizations. Vaccination of people with known current SARS-CoV-2 infection should be deferred until the person has recovered from the acute illness (if the person had symptoms) and they have met criteria to discontinue isolation. This recommendation applies to people who experience SARS-CoV-2 infection before receiving any vaccine dose and those who experience SARS- CoV-2 infection after the first dose of an mRNA vaccine but before receipt of the second dose. While there was no recommended minimum interval between infection and vaccination, current evidence suggests that the risk of SARS-CoV-2 reinfection was low in the months after initial infection but may increase with time due to waning immunity. Advised the caller that this document did not advise to restart the vaccination series but to wait until after isolation period and recovered from acute illness as noted above with no "designated minimal time interval." The patient underwent lab tests and procedures which included oxygen saturation: 84 to 86 % on 30Jul2021 oxygen levels, sars-cov-2 test: positive on 01Aug2021, sars-cov-2 test: positive on 30Jul2021. Outcome of the event shortness of breath was recovered on an unspecified date in 2021 and for another event, it was unknown. There was a Product Complaint and description of complaint included Caller''s daughter received first COVID19 Vaccine dose on Thursday. The next day she started having shortness of breath. Caller took her daughter to the hospital and she tested positive for COVID. The reason caller took her daughter to get tested is because her daughter is a severe asthmatic and said she was having trouble breathing. She had put the pulse oximeter on and oxygen level was 84 to 86%. In the ER they gave her a breathing treatment and ordered a spacer for her inhaler. She has been ok since. COVID19 Vaccine: the writing is a little bad on the card. The lot number is FAY485 or FAYU85. It was first dose. Product strength and count size dispensed: unknown Additional lot numbers: n/a Is a sample of the product available to be returned, if requested (Y/N): Not Provided Packaging sealed and intact? Not Provided; Sender''s Comments: As there is limited information in the case provided, the causal association between the events covid-19 and dyspnea the suspect drug cannot be excluded. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 1647001 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: New York  
Vaccinated:2021-07-03
Onset:2021-07-07
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-08-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0186 / 2 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain
SMQs:, Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101034710

Write-up: Four days after receiving vaccine started having chest pain; This is a spontaneous report from a contactable consumer (patient). A 16 years old male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in arm left at age of 16 years on 03Jul2021 (Lot Number: EW0186) as single dose for covid-19 immunisation. Medical history was none. There were no concomitant medications, patient didn''t receive any other vaccines within 4 weeks prior to the COVID vaccine, no other medications the patient received within 2 weeks of vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration, administered in arm left at age of 15 years on 12Jun2021 (lot number: EW0177) for covid-19 immunisation. Four days after receiving vaccine patient started having chest pain on 07Jul2021 10:00 and hospitalized for 4 days, unspecified medication was received as treatment. The event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care (as reported). Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event was unknown. No follow-up attempts are needed. No further information is expected.


VAERS ID: 1655087 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Male  
Location: Kentucky  
Vaccinated:2021-07-18
Onset:2021-08-18
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-08-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 RA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Appendicitis
SMQs:

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101081999

Write-up: appendicitis; This is a spontaneous report from a contactable consumer (the patient). An 18-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Right on 18Jul2021 14:00 at age of 18-year-old at single dose for COVID-19 immunisation, it also reported the patient received other vaccine at first dose on 18Jul2021 in right arm. Medical history was none. No known allergies, no other medical history. There were no concomitant medications (no other vaccine in four weeks, no other medications in two weeks). No prior COVID vaccination. No COVID tested post vaccination. The patient experienced appendicitis on 18Aug2021 18:00. The event resulted in hospitalization, life threatening illness (immediate risk of death from the event). The patient was hospitalized for the event for 2 days. Treatment for the event included surgery. The outcome of the event was recovered with sequelae (Recovered with lasting effects) in Aug2021. The lot number for BNT162B was not provided and will be requested during follow up.


VAERS ID: 1678801 (history)  
Form: Version 2.0  
Age: 12.0  
Sex: Female  
Location: Colorado  
Vaccinated:2021-07-29
Onset:2021-08-15
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EWO196 / 2 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Bacterial test negative, Blood creatine phosphokinase normal, Blood immunoglobulin G, Blood immunoglobulin M, Blood lactate dehydrogenase increased, Blood magnesium normal, Blood phosphorus increased, Blood thyroid stimulating hormone decreased, Blood uric acid normal, C-reactive protein decreased, Differential white blood cell count, Electric shock sensation, Feeling hot, Full blood count normal, Metabolic function test, Metabolic function test normal, Nerve conduction studies normal, Pain, Pain in extremity, Parvovirus B19 test negative, Porphyrins urine normal, Red blood cell sedimentation rate normal, Renal function test normal, SARS-CoV-2 test negative, Sensory disturbance, Serum ferritin normal, Urine analysis, Varicella virus test negative, Vitamin B12 normal, Vitamin B6, X-ray normal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Hypothyroidism (broad), Hyperthyroidism (broad), Chronic kidney disease (broad), Tumour lysis syndrome (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Pre-Teen Mulitvitamin, Probitoics, L-lysine, Vitamin C
Current Illness: Phyto-photodermatitis on primarily on Right Hand, some of Left fingers - occured from exposure to citrus juice on June 18 - lasted for nearly 7 weeks. Cold Sore
Preexisting Conditions: NA
Allergies: NA
Diagnostic Lab Data: 8/17 8/19 Xrays - nothing significant 8/25 Nerve EMG study - negative 8/26 1SARS COV-2 - negative 8/22 CBC with DIFF - nothing significant 8/22 Comp Metabolic Panel - nothing significant 8/22 CK/Creatine Kinase - 72 8/22 LDH total - 620 8/22 Uric Acid - 6.3 8/22 TSH - 1.04 8/22 C-Reactive Protein <0.5 8/22 SED RATE - 5 8/22 Phosphorus - 5.49 8/22 Magnesium - 2.1 8/26 Lyme - NEGATIVE 8/26 Ferritin - 28.60 8/26 B12 - 649 8/26 B6 Profile - Pyridoxal - 11 / Pyridoxic Acid - 3 8/27 Microscopic UA - nothing 8/27 Urinalysis with Microscopic - NOTHING 8/27 Porphyrins, QN, 22 to 26, HR Collection Only, U - NOTHING 8/28 Parvovirus - NOTHING 9/3 CBC with DIFF - Nothing significant 9/3 Renal Function Panel - nothing 9/3 Varicella - Zoster AB, IGG, S - Equivocal 9/3 Varicella-Zoster, AB, IGM - Negative Awaiting Genetic testing for Fabrys Disease and Erythtromelalgia
CDC Split Type:

Write-up: Woke up on 8/15 with significant pain in both hands - from wrists to fingers. No medication, treatment has relieved the pain in any manner - except ice. Pain intensity has increased signficantly and spread to both feet (mid-foot to toes) as well. Pain sensation began as "achy", then progressed to "sharp stabbing" and now includes "shocking" in addition to the "stabbing" pain. Both hands and feet are warm to the touch despite being iced nearly non-stop. (3) ED visits on 8/22, 8/24 and 8/26 with admittance to Hospital on 8/27 and discharged on 9/5. Most recently, she has shared the sensation of all fingers being "jammed".


VAERS ID: 1682808 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-07-12
Onset:2021-07-18
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-09-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Pulmonary embolism, Vena cava thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: -History of left iliofemoral deep venous thrombosis and pulmonary embolism in setting of May-Thurner anatomy & recent surgery in February 2020. Iliac stent placed in March 2020. -Depression and anxiety
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient developed chest pain approximately 6 days after receiving first dose of Pfizer vaccine. He presented to the ER on 7/23/21 (11 days after vaccine) and was found to have a pulmonary embolism and deep venous thrombosis in his inferior vena cava (IVC).


VAERS ID: 1684871 (history)  
Form: Version 2.0  
Age: 15.0  
Sex: Male  
Location: Georgia  
Vaccinated:2021-07-13
Onset:2021-09-09
   Days after vaccination:58
Submitted: 0000-00-00
Entered: 2021-09-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA6780 / 2 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Cerebral infarction, Craniectomy, Imaging procedure, Laboratory test, Mental status changes
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: none
Preexisting Conditions:
Allergies: amoxicillin
Diagnostic Lab Data: multiple labs and imaging
CDC Split Type:

Write-up: developed altered mental status with large left MCA territory infarction, required hemicraniectomy


VAERS ID: 1694238 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: Kansas  
Vaccinated:2021-07-21
Onset:2021-08-01
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-09-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8735 / 1 UN / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FC3180 / 2 UN / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Asthenia, Computerised tomogram thorax, Cough, Hypoxia, Organising pneumonia, Paraesthesia, Wheezing
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Asthma/bronchospasm (broad), Peripheral neuropathy (broad), Interstitial lung disease (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Fluticasone, albuterol, hydroxyzine
Current Illness:
Preexisting Conditions:
Allergies: None
Diagnostic Lab Data: CT angio chest on 9/10/21
CDC Split Type:

Write-up: Dry cough developed approximately 1 week after receiving vaccine #1. Two days after receiving vaccine #2 on 8/11/21, patient developed tingling in his legs and weakness. Since the end of August 2021 he has developed worsening cough and wheezing. He was admitted on 9/10/21 for hypoxia and found to have cryptogenic organizing pneumonia.


Result pages: prev   2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=11&VAX=COVID19&VAXMAN=PFIZER/BIONTECH&HOSPITAL=Yes&DIED=No&WhichAge=range&LOWAGE=(0)&HIGHAGE=(19)&VAX_YEAR_LOW=2021&VAX_MONTH_LOW=07&VAX_YEAR_HIGH=2021&VAX_MONTH_HIGH=07


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166